Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00WOT
|
|||
Former ID |
DIB008941
|
|||
Drug Name |
CDP-850
|
|||
Synonyms |
VLA-4, Celltech; Anti-E-selectin antibody, Celltech
Click to Show/Hide
|
|||
Drug Type |
Antibody
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
Company |
UCB Celltech
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | P-selectin (SELP) | Target Info | . | [2] |
KEGG Pathway | Cell adhesion molecules (CAMs) | |||
Malaria | ||||
Staphylococcus aureus infection | ||||
Pathway Interaction Database | IL4-mediated signaling events | |||
amb2 Integrin signaling | ||||
Reactome | Platelet degranulation | |||
Cell surface interactions at the vascular wall | ||||
WikiPathways | Human Complement System | |||
Spinal Cord Injury | ||||
Cell surface interactions at the vascular wall |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007242) | |||
REF 2 | WO patent application no. 2001,0276,21, Competitive inhibition elisa for antibody detection. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.